Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effective and safe examination of Luseogliflozin for patients with fatty liver merger type II diabetes mellitus

X
Trial Profile

Effective and safe examination of Luseogliflozin for patients with fatty liver merger type II diabetes mellitus

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 22 Feb 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Luseogliflozin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms LEAD
  • Most Recent Events

    • 01 Jan 2019 Primary endpoint (Rate of change of fat ratio in the liver) has been met as per results published in the Hepatology Research
    • 01 Jan 2019 Primary endpoint (Change in HbA1c) has been met as per results published in the Hepatology Research
    • 01 Jan 2019 Results published in the Hepatology Research
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top